American ethnic groups less likely to have cholesterol controlled

November 10, 2004

NEW ORLEANS, Nov. 10 - Compared with non-Hispanic whites, non-Hispanic blacks and Hispanics who qualify for cholesterol-lowering drug treatment are less likely to have their "bad" LDL cholesterol controlled to recommended levels, researchers reported at the American Heart Association's Scientific Sessions 2004.

"This study is the first large-scale, comparative evaluation of cholesterol treatment and control in four major U.S. ethnic groups," said David C. Goff, M.D., Ph.D., the report's first author and a professor of public health science and internal medicine at the Wake Forest University School of Medicine in Winston-Salem, N.C.

Researchers examined the cholesterol levels of 6,704 of the 6,814 participants in the Multi-Ethnic Study of Atherosclerosis (MESA), funded by the National Heart, Lung, and Blood Institute. This ongoing study seeks to discover if any differences exist between ethnic groups in the development of heart disease.

The study measured prevalence and control of high cholesterol among the four ethnic groups, and found striking differences in treatments. Almost half did not reach their goal. Thus, only 22 percent of the 1,494 patients who qualified for medications had their cholesterol under control.

Among all ethnic groups studied, only one in five Americans who qualify to take drugs to lower their high cholesterol levels have their LDL cholesterol under control.

"We were interested in assessing how often people are getting their cholesterol treated when it is high enough to warrant treatment," Goff said. "Treating high cholesterol can reduce the risk of heart disease by about 30 percent."

MESA researchers enrolled study participants in 2001 and 2002 in six metropolitan areas: Baltimore, Chicago, Los Angeles, Minneapolis-St. Paul, New York City and Winston-Salem, N.C. The study was designed to have a diverse ethnic mix.

Participants were age 45 to 84 at their time of entry and had no symptoms of cardiovascular disease. Each completed a health survey, underwent a physical exam and laboratory tests, and some had imaging studies. In assessing enrollees' cholesterol levels and need for cholesterol-lowering treatment, the researchers used 2001 treatment guidelines commonly known as ATPIII. The Adult Treatment Panel of the National Heart, Lung, and Blood Institute's National Cholesterol Education Program formulated the ATPIII guidelines.

ATPIII recommends treatment based on a person's blood level of LDL cholesterol. The threshold level for LDL treatment, either with lifestyle changes or drugs, depends on whether a person has heart disease, diabetes or other risk factors, Goff said.

For some people, the recommended level is less than 100 milligrams per deciliter (mg/dL); for others it's less than 130 mg/dL; and for still others it's less than 160 mg/dL. In recommendations published in 2004, a very-high risk group was identified with a goal of less than 70 mg/dL.

"The implications of this study are that high cholesterol is very common, treatment is far from ideal, and disparities in control persist," Goff said. "We have very effective treatments for high blood cholesterol, but for people to benefit, they must have their cholesterol measured, have treatment prescribed by physicians, and take the medication as advised."

The new findings confirm data from the fourth National Health and Nutritional Examination Survey (NHANES IV) assessing total cholesterol treatment and control among blacks, whites, and Mexican Americans. It showed lower rates of control among both blacks and Mexican Americans than whites, but did not assess treatment in relation to the ATPIII recommendations.

"The public needs to become more aware of the importance of getting their cholesterol checked and being treated if it is high, because informed patients can make sure they get good care," Goff said. "Physicians and other healthcare professionals need to work together to improve the quality of care that is delivered to patients with high cholesterol."

Co-authors are Alain G. Bertoni, M.D.; Denise E. Bonds, M.D.; Holly Kramer, M.D.; Michael Y. Tsai, Ph.D.; Roger Blumenthal, M.D., and Bruce M. Psaty, M.D., Ph.D.
-end-
Statements and conclusions of study authors that are published in the American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect association policy or position. The American Heart Association makes no representation or warranty as to their accuracy or reliability.

This news release is featured in a news conference.

Abstract 3778
(Note: This news release contains updated data from the abstract)

American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.